logo

[breadcrumb_custom]

Altimmune Inc (ALT) Stock: A Year of Highs and Lows

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Altimmune Inc’s current trading price is -36.96% away from its 52-week high, while its distance from the 52-week low is 347.61%. The stock’s price range over this period has fluctuated between $2.09 and $14.84. The company, operating within the financial sector, had a trading volume of approximately 3.63 million for the day, which was noticeably lower than the average daily share volume of 6.05 million over the last 3 months.

Altimmune Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $14.84 on 02/28/24, while the lowest price for the same duration was marked at $2.09 on 10/23/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Altimmune Inc (ALT) has experienced a quarterly decline of -16.84% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 663.27M and boasts a workforce of 59 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.38, with a change in price of +6.68. Similarly, Altimmune Inc recorded 9,162,381 in trading volume during the last 100 days, posting a change of +250.37%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ALT stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ALT Stock Stochastic Average

Today’s raw stochastic average for Altimmune Inc over the last 50 days is 20.74%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 37.32%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 45.65% and 43.87%, respectively.

ALT Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded a decrease of -16.84%. However, over the last six months, the performance has been weaker by 259.81%. The price of ALT decreased -22.62% over the last 30 days. And in the last five days, it has surged by 9.67%.

On Key

Related Posts